666 / 1173
1/03/2016
5
Eriksen Radiother Oncol 2005
EGFR expression & prognosis
HR 0.62
HR 0.70
Eriksen, DAHANCA 6,7
EGFR expression & prognosis
•
Tumors with
high EGFr
and
well/moderate differentiation
did
benefit from moderate acceleration of
treatment regarding locoregional
control, HR 0.54 (0.37-0.78)
•
Such an effect was not seen in tumors
with
low EGFr and/or poor
differentiation
, HR 0.8 (0.51-1.25).